findmyKOL

Fasika Tedla, MD

Basic profile

Mount Sinai Hospital

ORCIDNPI
RegionNew York, NY · NortheastSpecialtyNephrologyFocusNephrology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Fasika Tedla is a Nephrology physician affiliated with Mount Sinai Hospital. OpenAlex indexes 81 publications with 704 citations (h-index 13).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
81publications

Distinct works indexed by OpenAlex, matched via ORCID.

704citations

Total citations across indexed works.

13h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

5 E 98th St Fl 12
New York, NY 100296501

Telephone

212-659-8086

Registry record last updated 7 Nov 2019.

View the NPPES registry record

Industry payments

2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    40.4%
    Beta blocker13.2%
    Metoprolol Succinate55%Carvedilol28%Metoprolol Tartrate17%
    Part D<11 patients
    Calcium channel blocker11.1%
    Nifedipine Er54%Amlodipine Besylate25%Diltiazem 24hr Er (Cd)21%
    Part D<11 patients

    + 4 more classes in this area

  • Metabolism & gastrointestinal

    23.2%
    Corticosteroid12.1%
    Prednisone100%
    Part D15 patients
    Proton pump inhibitor5.1%
    Pantoprazole Sodium100%
    Part D<11 patients

    + 2 more classes in this area

  • Anti-infectives

    13.9%
    Short-acting sulfonamides13.9%
    Sulfamethoxazole-Trimethoprim100%
    Part D24 patients
Where care is delivered (Part B)40.2% facility · 59.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”